Kalos Management, Inc. Bionano Genomics, Inc. Transaction History

Kalos Management, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$12.3 - $27.3 $9,840 - $21,840	-800 Reduced 3.01%	25,820 $35,000
Q1 2022 Jun 21, 2022	BUY	$16.6 - $32.3 $122,508 - $238,373	7,380 Added 38.36%	26,620 $68,000
Q4 2021 Feb 03, 2022	BUY	$29.9 - $61.2 $22,126 - $45,288	740 Added 4.0%	19,240 $105,000
Q3 2021 Nov 10, 2021	BUY	$51.4 - $68.2 $107,940 - $143,220	2,100 Added 12.8%	18,500 $101,000
Q2 2021 Aug 11, 2021	BUY	$44.1 - $84.0 $209,475 - $399,000	4,750 Added 40.77%	16,400 $112,000
Q1 2021 May 13, 2021	BUY	$47.0 - $155.7 $547,550 - $1.81 Million	11,650 New	11,650 $74,000

4.97K

Ticker BNGO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 290,140,000
Market Cap $63.8M
Description
Bionano Genomics, Inc. provides genome analysis software solutions. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel...

Get notified when there are updates to the investment portfolio of Kalos Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Kalos Management, Inc. with notifications on news.